Diabetes Care 2024: Pharmacologic Approaches to Glycemic Treatment
In the annual update of American Diabetes Association standards for diabetes care, the recommendations for pharmacotherapy now include a preference for insulin analogs or inhaled
In the annual update of American Diabetes Association standards for diabetes care, the recommendations for pharmacotherapy now include a preference for insulin analogs or inhaled
In the annual update of American Diabetes Association standards for diabetes care, the language used for obesity and weight management for the prevention and treatment
In its annual update of standards for diabetes care, the American Diabetes Association makes several key changes for the diverse population of older adults. For
Treatment with metformin plus insulin people with preexisting type 2 or gestational diabetes diagnosed early in pregnancy did not reduce a composite neonatal adverse outcome
Two studies and an editorial explore the use of Janus kinase (JAK) inhibitors for preserving pancreatic β-cell function and preventing disease progression in type 1
Early reduction in albuminuria by finerenone accounts for “a large proportion of the treatment effect against CKD progression and a modest proportion of the effect
Wearable glucose sensors, automated insulin delivery (AID), and smartphone technology “illustrate how digital health technology can aid providers caring for patients with diabetes,” authors write
Used for managing type 1 diabetes (T1D) in ambulatory children and adolescents, automated insulin delivery (AID) systems are more effective than conventional insulin therapy, a
Weight loss was maintained for up to 36 months in patients with overweight/obesity and prediabetes who participated in shared decision-making (SDM) for diabetes prevention, researchers
In a cohort study, unvaccinated people with COVID-19 had a 62% higher chance of developing new-onset diabetes mellitus (DM), while vaccinated individuals with breakthrough COVID-19